John Bomalaski
Corporate Officer/Principal en POLARIS GROUP .
Cargos activos de John Bomalaski
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| POLARIS GROUP | Corporate Officer/Principal | 01/01/2007 | - |
| Director/Miembro de la Junta | 15/04/2006 | - | |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Director Técnico/Científico/I+D | - | - |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | 18/12/2009 | - | |
| DRX USA | Director/Miembro de la Junta | - | - |
| DesigneRx Europe Ltd. | Director/Miembro de la Junta | - | - |
| Polaris Group Korea Ltd. | Director/Miembro de la Junta | - | - |
Historial de carrera de John Bomalaski
Antiguos cargos conocidos de John Bomalaski.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - | - |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - | - |
Formación de John Bomalaski.
| St. Louis University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| España | 2 |
| Taiwán | 2 |
Operativa
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Empresas privadas | 5 |
|---|---|
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DRX USA | |
| DesigneRx Europe Ltd. | |
| Polaris Group Korea Ltd. |
- Bolsa de valores
- Insiders
- John Bomalaski
- Experiencia
